Cargando…

A New Role for CXCL4 in Respiratory Syncytial Virus Disease

Detalles Bibliográficos
Autores principales:	Wiseman, Dexter J., Thwaites, Ryan S., Openshaw, Peter J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462410/ https://www.ncbi.nlm.nih.gov/pubmed/32645278 http://dx.doi.org/10.1164/rccm.202006-2154ED

Ejemplares similares

The Respiratory Mucosa: Front and Center in Respiratory Syncytial Virus Disease
por: Thwaites, Ryan S., et al.
Publicado: (2019)

Mucosal Immune Responses to Respiratory Syncytial Virus
por: Barnes, Megan V. C., et al.
Publicado: (2022)

Potential therapeutic implications of new insights into respiratory syncytial virus disease
por: Openshaw, Peter JM
Publicado: (2002)

Respiratory Syncytial Virus (RSV) Update
por: Krilov, Leonard R., et al.
Publicado: (2022)

An update on respiratory syncytial virus
por: Piralla, Antonio, et al.
Publicado: (2023)

Immunoprophylaxis against respiratory syncytial virus with palvizumab: what is new?
por: Sáfadi, Marco Aurélio P.
Publicado: (2014)

Pathobiology of Respiratory Syncytial Virus (RSV)
por: Tripp, Ralph A., et al.
Publicado: (2020)

Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses
por: Siggins, Matthew K., et al.
Publicado: (2021)

Respiratory syncytial virus (RSV) disease – new data needed to guide future policy
por: Campbell, Harry, et al.
Publicado: (2015)

A41 Deep sequencing of respiratory syncytial virus links viral diversity to disease severity
por: Nauwelaers, Inne, et al.
Publicado: (2019)

Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus–Induced Immunopathology
por: Walzl, Gerhard, et al.
Publicado: (2000)

Fail-Fast in Respiratory Syncytial Virus Vaccine Development
por: Besteman, Sjanna B., et al.
Publicado: (2019)

The Changing Landscape of Respiratory Syncytial Virus Infections
por: Bem, Reinout A., et al.
Publicado: (2023)

Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses: (Trends in Microbiology, 29, 648–662, 2021)
por: Siggins, Matthew K., et al.
Publicado: (2021)

Respiratory Syncytial Virus Infection in High-Risk Infants
por: Resch, Bernhard
Publicado: (2011)

Live-attenuated Respiratory Syncytial Virus Vaccines: Time for the Next Step
por: Billard, Marie-Noëlle, et al.
Publicado: (2021)

Delayed Sequelae of Neonatal Respiratory Syncytial Virus Infection Are Dependent on Cells of the Innate Immune System
por: Harker, James A., et al.
Publicado: (2014)

[Translated article] Where does Respiratory Syncytial Virus Hide?
por: Martinón-Torres, Federico, et al.
Publicado: (2022)

Respiratory syncytial virus infection in COVID-19 times: Trick or threat?
por: Menasalvas Ruiz, Ana Isabel
Publicado: (2023)

Respiratory syncytial virus infection in COVID-19 times: Trick or threat?
por: Menasalvas Ruiz, Ana Isabel
Publicado: (2023)

New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic
por: Teirlinck, Anne C., et al.
Publicado: (2023)

A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease
por: Polack, Fernando P., et al.
Publicado: (2002)

Respiratory Syncytial Virus Infection in the Aftermath of COVID-19: Is It a Case of Old Wine in a New Bottle?
por: Parameswaran, Narayanan
Publicado: (2022)

The epidemiology and risk factors of respiratory syncytial virus and its impact on the timing of immunoprophylaxis
por: Jeena, Prakash Mohan
Publicado: (2018)

Utilization Management Opportunities for Palivizumab for Prophylaxis of Respiratory Syncytial Virus Complications in Infants
por: Curtiss, Frederic R., et al.
Publicado: (2010)

Association between respiratory syncytial virus hospitalization in infancy and childhood asthma
por: Coutts, Jonathan, et al.
Publicado: (2020)

Dynamical Differences in Respiratory Syncytial Virus
por: Heumann, Ryan, et al.
Publicado: (2021)

Respiratory syncytial virus
por: Munoz, Flor M., et al.
Publicado: (2020)

Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013)

Respiratory syncytial virus
por: Ruuskanen, Olli, et al.
Publicado: (1993)

Role of Respiratory Syncytial Virus in Pediatric Pneumonia
por: Bianchini, Sonia, et al.
Publicado: (2020)

SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses
por: Swets, Maaike C, et al.
Publicado: (2022)

IL-10 Regulates Viral Lung Immunopathology during Acute Respiratory Syncytial Virus Infection in Mice
por: Loebbermann, Jens, et al.
Publicado: (2012)

Regulatory T Cells Prevent Th2 Immune Responses and Pulmonary Eosinophilia during Respiratory Syncytial Virus Infection in Mice
por: Durant, Lydia R., et al.
Publicado: (2013)

RESPIRATORY SYNCYTIAL AND OTHER VIRUSES ASSOCIATED WITH RESPIRATORY DISEASE IN INFANTS
por: Jacobs, J.W., et al.
Publicado: (1971)

Respiratory Syncytial Virus Resurgence in Italy: The Need to Protect All Neonates and Young Infants
por: Bozzola, Elena
Publicado: (2021)

Nirsevimab brings breakthrough in the prevention of respiratory syncytial virus infection in infants – Importance of design
por: Zhaori, Getu
Publicado: (2023)

Respiratory syncytial virus: The virus, the disease and the immune response
por: Ogra, Pearay L.
Publicado: (2004)

Alpha/Beta Interferon Receptor Signaling Amplifies Early Proinflammatory Cytokine Production in the Lung during Respiratory Syncytial Virus Infection
por: Goritzka, Michelle, et al.
Publicado: (2014)

The Future of Respiratory Syncytial Virus Disease Prevention and Treatment
por: Domachowske, Joseph B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6eru3rppm9sp0snu0nv9qhl582